Retinalamin, lyophilizate 5 mg 22 mg 10 pcs

Retinalamin is a tissue repair stimulator. Retinalamin is a complex of water-soluble polypeptide fractions with a molecular weight of no more than 10,000 Da.

The drug has a stimulating effect on photoreceptors and cellular elements of the retina and improves functional interaction of the pigment epithelium and outer segments of the photoreceptors and glial cells in case of dystrophic changes and accelerates restoration of light sensitivity of the retina.

Normalizes vascular permeability, reduces manifestations of local inflammatory reactions and stimulates reparative processes in retinal diseases and injuries.

The mechanism of action of Retinalamin is determined by its metabolic activity: the drug improves metabolism of eye tissue and normalizes cell membrane function, improves intracellular protein synthesis, regulates lipid peroxidation and helps optimize energy processes.

Pharmacokinetics

The composition of Retinalamin, the active substance of which is a complex of polypeptide fractions, does not allow the usual pharmacokinetic analysis of its components.

Indications

compensated primary open-angle glaucoma;
diabetic retinopathy;
central retinal dystrophy of inflammatory and traumatic origin;
central retinal dystrophy;
myopic disease (as part of complex therapy);
central and peripheral taperetinal abiotrophy.

Pharmacological effect

Retinalamin is a tissue repair stimulator. Retinalamin is a complex of water-soluble polypeptide fractions with a molecular weight of no more than 10,000 Da.

The drug has a stimulating effect on photoreceptors and cellular elements of the retina, helps improve the functional interaction of the pigment epithelium and the outer segments of photoreceptors, glial cells during dystrophic changes, and accelerates the restoration of light sensitivity of the retina.

Normalizes vascular permeability, reduces the manifestations of local inflammatory reaction, stimulates reparative processes in diseases and injuries of the retina.

The mechanism of action of Retinalamin is determined by its metabolic activity: the drug improves the metabolism of eye tissue and normalizes the functions of cell membranes, improves intracellular protein synthesis, regulates lipid peroxidation processes, and helps optimize energy processes.

Pharmacokinetics

The composition of Retinalamin, the active substance of which is a complex of polypeptide fractions, does not allow for the usual pharmacokinetic analysis of its components.

Active ingredient

Livestock retinal polypeptides

Composition

1 bottle contains:

Active substance:

retinalamine (complex of water-soluble polypeptide fractions of the retina of livestock eyes) 5 mg;

Excipient:

glycine 17 mg.

Pregnancy

The drug is contraindicated during pregnancy (there is no data on effectiveness and safety).

If it is necessary to prescribe the drug during lactation, breastfeeding should be stopped.

Contraindications

individual hypersensitivity to the components of the drug;
age under 18 years – with compensated primary open-angle glaucoma, diabetic retinopathy, myopic disease (due to the lack of data on effectiveness and safety);
age up to 1 year – with central retinal dystrophy of inflammatory and traumatic origin, central and peripheral taperetinal abiotrophy.

Storage conditions

In a dry place, protected from light, at a temperature of 2 to 20 °C

Shelf life

2 years

Manufacturer

Geropharm LLC, Russia